Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02856503
What this trial is testing

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

Who this might be right for
Breast CancerInvasive Breast CarcinomaDuctal Carcinoma In-situ
Eli Avisar, MD
Not applicableLooking for participantsNCT02620852
What this trial is testing

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Who this might be right for
Breast Cancer ScreeningBreast Carcinoma in SituBreast Cancer
University of California, San Francisco 100,000
Not applicableWithdrawnNCT02168179
What this trial is testing

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
Wake Forest University Health Sciences
Not applicableStudy completedNCT02216136
What this trial is testing

Tumor: Breast Ratio Study

Who this might be right for
Breast CancerLCISDCIS
Washington University School of Medicine 162
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)Study completedNCT00053898
What this trial is testing

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,104
Not applicableStudy completedNCT01293032
What this trial is testing

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more
Virginia Commonwealth University 59
Not applicableStudy completedNCT00388115
What this trial is testing

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, Davis 15
Not applicableLooking for participantsNCT07292246
What this trial is testing

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

Who this might be right for
Breast CancerBRCA 1 Gene MutationBRCA 2 Gene Mutation+5 more
Vasileios Kalles 15
Not applicableStudy completedNCT06257888
What this trial is testing

A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients

Who this might be right for
Breast Neoplasm Malignant Primary
Renato Cagnacci Neto 90
Early research (Phase 1)Study completedNCT00005886
What this trial is testing

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07762924
What this trial is testing

Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 234
Not applicableStudy completedNCT02766881
What this trial is testing

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS

Who this might be right for
DCIS
Ontario Clinical Oncology Group (OCOG) 281
Very early researchWithdrawnNCT02610920
What this trial is testing

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Who this might be right for
Breast NeoplasmCarcinoma, Ductal, BreastCarcinoma, Intraductal, Noninfiltrating
Columbia University
Testing effectiveness (Phase 2)Study completedNCT02637024
What this trial is testing

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation

Who this might be right for
Breast CancerDCIS
Ontario Clinical Oncology Group (OCOG) 280
Not applicableNot Yet RecruitingNCT07527468
What this trial is testing

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

Who this might be right for
Breast CancerDuctal Carcinoma In SituInvasive Lobular Carcinoma+1 more
Hôpital du Valais 228
Testing effectiveness (Phase 2)Ended earlyNCT00096369
What this trial is testing

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 130
Not applicableActive Not RecruitingNCT02515110
What this trial is testing

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Who this might be right for
Breast CancerNode-positive Breast CancerBreast Adenocarcinoma+2 more
Virginia Commonwealth University 137
Not applicableStudy completedNCT02248662
What this trial is testing

Impact of Radiation Therapy on Breast Conservation in DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 3,436
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Next Page